Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research

Angioletta Lasagna; Marta Muzzana; Paolo Pedrazzoli

doi:10.2217/imt-2021-0219

Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research

Immunotherapy. 2021 Dec;13(17):1369-1372. doi: 10.2217/imt-2021-0219. Epub 2021 Sep 29.

Authors

Angioletta Lasagna¹, Marta Muzzana^{1

2}, Paolo Pedrazzoli^{1

2}

Affiliations

¹ Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy.
² Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, 27100, Italy.

No abstract available

Keywords: COVID-19; cancer patients; cytokine storm; febrile neutropenia; proteomic profiling; recombinant human granulocyte-colony stimulating factors (rhG-CSFs).

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19* / epidemiology
COVID-19* / therapy
Granulocyte Colony-Stimulating Factor / therapeutic use*
Humans
Neoplasms / drug therapy*
Pandemics
SARS-CoV-2*

Substances

Granulocyte Colony-Stimulating Factor

Grants and funding

Ricerca Corrente grant no 08067620/Fondazione IRCCS Policlinico San Matteo